180 related articles for article (PubMed ID: 22641028)
1. ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder.
de Klerk OL; Nolte IM; Bet PM; Bosker FJ; Snieder H; den Boer JA; Bruggeman R; Hoogendijk WJ; Penninx BW
Pharmacogenomics J; 2013 Aug; 13(4):349-53. PubMed ID: 22641028
[TBL] [Abstract][Full Text] [Related]
2. ABCB1 gene variants and antidepressant treatment outcome: A meta-analysis.
Breitenstein B; Brückl TM; Ising M; Müller-Myhsok B; Holsboer F; Czamara D
Am J Med Genet B Neuropsychiatr Genet; 2015 Jun; 168B(4):274-83. PubMed ID: 25847751
[TBL] [Abstract][Full Text] [Related]
3. ABCB6, ABCB1 and ABCG1 genetic polymorphisms and antidepressant response of SSRIs in Chinese depressive patients.
Huang X; Yu T; Li X; Cao Y; Li X; Liu B; Yang F; Li W; Zhao X; Feng G; Zhang X; Dong Z; He L; Sun X; He G
Pharmacogenomics; 2013 Nov; 14(14):1723-30. PubMed ID: 24192121
[TBL] [Abstract][Full Text] [Related]
4. ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.
Kato M; Fukuda T; Serretti A; Wakeno M; Okugawa G; Ikenaga Y; Hosoi Y; Takekita Y; Mandelli L; Azuma J; Kinoshita T
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):398-404. PubMed ID: 17913323
[TBL] [Abstract][Full Text] [Related]
5. Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depressive disorder.
Simoons M; Mulder H; Appeldoorn JTY; Risselada AJ; Schene AH; van Schaik RHN; van Roon EN; Ruhé EG
Psychiatr Genet; 2020 Feb; 30(1):19-29. PubMed ID: 31634334
[TBL] [Abstract][Full Text] [Related]
6. Post-mortem analysis of suicide victims shows ABCB1 haplotype 1236T-2677T-3435T as a candidate predisposing factor behind adverse drug reactions in females.
Rahikainen AL; Palo JU; Haukka J; Sajantila A
Pharmacogenet Genomics; 2018 Apr; 28(4):99-106. PubMed ID: 29481489
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein (PGP) polymorphisms and sexual dysfunction in female patients with depression and SSRI-associated sexual side effects.
Bly MJ; Bishop JR; Thomas KL; Ellingrod VL
J Sex Marital Ther; 2013; 39(3):280-8. PubMed ID: 23356581
[TBL] [Abstract][Full Text] [Related]
8. ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 Study.
Magarbeh L; Hassel C; Choi M; Islam F; Marshe VS; Zai CC; Zuberi R; Gammal RS; Men X; Scherf-Clavel M; Enko D; Frey BN; Milev R; Soares CN; Parikh SV; Placenza F; Strother SC; Hassel S; Taylor VH; Leri F; Blier P; Farzan F; Lam RW; Turecki G; Foster JA; Rotzinger S; Kloiber S; Kennedy JL; Kennedy SH; Bousman CA; Müller DJ
Clin Pharmacol Ther; 2023 Jul; 114(1):88-117. PubMed ID: 36681895
[TBL] [Abstract][Full Text] [Related]
9. ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression.
Singh AB; Bousman CA; Ng CH; Byron K; Berk M
Transl Psychiatry; 2012 Nov; 2(11):e198. PubMed ID: 23188198
[TBL] [Abstract][Full Text] [Related]
10. ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression.
Ray A; Tennakoon L; Keller J; Sarginson JE; Ryan HS; Murphy GM; Lazzeroni LC; Trivedi MH; Kocsis JH; DeBattista C; Schatzberg AF
Pharmacogenomics J; 2015 Aug; 15(4):332-9. PubMed ID: 25487678
[TBL] [Abstract][Full Text] [Related]
11. Ethnicity-related polymorphisms and haplotypes in the human ABCB1 gene.
Kimchi-Sarfaty C; Marple AH; Shinar S; Kimchi AM; Scavo D; Roma MI; Kim IW; Jones A; Arora M; Gribar J; Gurwitz D; Gottesman MM
Pharmacogenomics; 2007 Jan; 8(1):29-39. PubMed ID: 17187507
[TBL] [Abstract][Full Text] [Related]
12. Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study.
Nikisch G; Eap CB; Baumann P
Pharmacol Res; 2008; 58(5-6):344-7. PubMed ID: 18940259
[TBL] [Abstract][Full Text] [Related]
13. Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study.
Breitenstein B; Scheuer S; Brückl TM; Meyer J; Ising M; Uhr M; Holsboer F
J Psychiatr Res; 2016 Feb; 73():86-95. PubMed ID: 26704739
[TBL] [Abstract][Full Text] [Related]
14. Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design.
Geers LM; Ochi T; Vyalova NM; Losenkov IS; Paderina DZ; Pozhidaev IV; Simutkin GG; Bokhan NA; Wilffert B; Touw DJ; Loonen AJM; Ivanova SA
Hum Psychopharmacol; 2022 May; 37(3):e2826. PubMed ID: 34788473
[TBL] [Abstract][Full Text] [Related]
15.
Santos M; Lima L; Carvalho S; Brandão A; Barroso F; Cruz A; Medeiros R
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791151
[TBL] [Abstract][Full Text] [Related]
16. Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population.
Fujii T; Ota M; Hori H; Sasayama D; Hattori K; Teraishi T; Yamamoto N; Hashikura M; Tatsumi M; Higuchi T; Kunugi H
J Psychiatr Res; 2012 Apr; 46(4):555-9. PubMed ID: 22306099
[TBL] [Abstract][Full Text] [Related]
17. Roles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomes.
Wu H; Kang H; Liu Y; Tong W; Liu D; Yang X; Lian M; Yao W; Zhao H; Huang D; Sha X; Wang E; Wei M
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1449-62. PubMed ID: 22526155
[TBL] [Abstract][Full Text] [Related]
18.
Shan XX; Qiu Y; Xie WW; Wu RR; Yu Y; Wu HS; Li LH
Front Pharmacol; 2019; 10():761. PubMed ID: 31333472
[No Abstract] [Full Text] [Related]
19. One-Year Follow-up of Children and Adolescents with Major Depressive Disorder: Relationship between Clinical Variables and Abcb1 Gene Polymorphisms.
Blázquez A; Gassó P; Mas S; Plana MT; Lafuente A; Lázaro L
Pharmacopsychiatry; 2016 Nov; 49(6):248-253. PubMed ID: 27309038
[No Abstract] [Full Text] [Related]
20. Bisphenol A (BPA) and bisphenol S (BPS) alter the promoter activity of the ABCB1 gene encoding P-glycoprotein in the human placenta in a haplotype-dependent manner.
Speidel JT; Xu M; Abdel-Rahman SZ
Toxicol Appl Pharmacol; 2018 Nov; 359():47-54. PubMed ID: 30240697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
